Cargando…
Hypocretin (orexin) cell loss in Parkinson’s disease
It has recently been reported that Parkinson’s disease (PD) is preceded and accompanied by daytime sleep attacks, nocturnal insomnia, REM sleep behaviour disorder, hallucinations and depression, symptoms which are frequently as troublesome as the motor symptoms of PD. All these symptoms are present...
Autores principales: | Thannickal, Thomas C., Lai, Yuan-Yang, Siegel, Jerome M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762453/ https://www.ncbi.nlm.nih.gov/pubmed/17491094 http://dx.doi.org/10.1093/brain/awm097 |
Ejemplares similares
-
Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson’s disease
por: Thannickal, Thomas C., et al.
Publicado: (2008) -
Editorial: Hypocretins/Orexins
por: López, Miguel, et al.
Publicado: (2020) -
Diurnal fluctuation in the number of hypocretin/orexin and histamine producing: Implication for understanding and treating neuronal loss
por: McGregor, Ronald, et al.
Publicado: (2017) -
Opiate anticipation, opiate induced anatomical changes in hypocretin (Hcrt, orexin) neurons and opiate induced microglial activation are blocked by the dual Hcrt receptor antagonist suvorexant, while opiate analgesia is maintained
por: McGregor, Ronald, et al.
Publicado: (2023) -
IGFBP3 Colocalizes with and Regulates Hypocretin (Orexin)
por: Honda, Makoto, et al.
Publicado: (2009)